Integris Wealth Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$421K Buy
3,277
+386
+13% +$45.2K 0.09% 82
2026
Q1
$348K Hold
2,891
0.08% 81
2025
Q4
$304K Hold
2,891
0.07% 91
2025
Q3
$243K Hold
2,891
0.06% 105
2025
Q2
$229K Buy
2,891
+465
+19% +$37K 0.06% 105
2025
Q1
$218K Sell
2,426
-28
-1% -$2.61K 0.06% 100
2024
Q4
$244K Hold
2,454
0.07% 90
2024
Q3
$279K Hold
2,454
0.08% 79
2024
Q2
$304K Hold
2,454
0.09% 72
2024
Q1
$324K Sell
2,454
-60
-2% -$7.39K 0.09% 67
2023
Q4
$274K Hold
2,514
0.08% 78
2023
Q3
$259K Hold
2,514
0.08% 78
2023
Q2
$290K Sell
2,514
-329
-12% -$37.4K 0.1% 63
2023
Q1
$302K Hold
2,843
0.11% 61
2022
Q4
$315K Buy
+2,843
New +$291K 0.12% 58

Other funds holding MRK

Integris Wealth Management's MRK Position: Q2 2026 in Review

Integris Wealth Management increased its Merck (MRK) stake by 13% in Q2 2026, buying an estimated $45.2K and bringing the position to 3,277 shares worth $421K. The position accounts for 0.09% of the portfolio, ranked #82.

Integris Wealth Management first reported a position in MRK in Q4 2022 and has held it in 15 quarters since. 1,299 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Integris Wealth Management held 3,277 shares of Merck worth $421K as of Q2 2026.
  • Integris Wealth Management bought 386 Merck shares in Q2 2026, an estimated $45.2K.
  • Merck made up 0.09% of Integris Wealth Management's portfolio in Q2 2026, its #82 holding.
  • Integris Wealth Management first reported a position in Merck in Q4 2022 and has held it in 15 quarters since.
  • 1,299 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Integris Wealth Management's 13F filing for Q2 2026, filed 13 Jul 2026.